Advita Ortho

Advita Ortho

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Advita Ortho is a private, commercial-stage medical device company at the forefront of integrating artificial intelligence into orthopedic surgery. Its flagship technology is the Active Intelligence® platform, which includes the GPS System—a pioneering AI-powered navigation platform for knee, shoulder, and ankle replacement that provides real-time intraoperative guidance. The company has a full portfolio of implants for primary and revision procedures and is actively expanding its installed base, having surpassed 100,000 GPS cases. Advita positions itself as a surgeon-centric alternative to robotic systems, emphasizing surgeon control and data-driven precision.

OrthopedicsMusculoskeletal Disorders

Technology Platform

Active Intelligence® surgical technology platform featuring the GPS System, an AI-powered surgical navigation platform for knee, shoulder, and ankle replacement. The platform integrates AI-driven preoperative planning, real-time intraoperative navigation, patient-specific instrumentation, and the AI One™ data intelligence and Chime™ clinical exchange platforms.

Opportunities

The growing global joint replacement market, especially in extremities like shoulder and ankle, presents a significant expansion opportunity.
The shift toward value-based care and data-driven surgery creates demand for AI-enabled platforms that can improve outcomes and surgical efficiency, positioning Advita's Active Intelligence® as a key solution.

Risk Factors

Intense competition from larger, well-established orthopedic giants with robotic systems poses a major market adoption risk.
Technological execution risk is high due to the complexity of integrating AI, navigation, and hardware, while evolving regulatory and reimbursement landscapes for digital surgery tools could impact profitability.

Competitive Landscape

Advita competes directly with major orthopedic companies offering robotic-assisted surgery platforms, such as Stryker (Mako), Zimmer Biomet (ROSA), and Johnson & Johnson (Velys). It differentiates by emphasizing AI-powered navigation without a robotic arm, positioning itself as a surgeon-controlled, potentially more cost-effective alternative in the high-growth digital surgery segment.